LinkedIn carousel ad examples

Your target class may already be curated: GOSTAR holds about 11 million compounds from patents and papers. Start from a ready cut, not a blank sheet.

A defensible landscape without pulling your team off their work. Excelra's PhD-led screening covers patents and papers, each finding traced to source.

Planning your ADLM schedule? Here are 3 reasons why a visit to Booth 3648 could be your most productive 15 minutes at this year's show. Whether you're looking to streamline assay development, improve manufacturing efficiency, or explore new partnership opportunities, Charlotte, Ish and Sarah will be on hand to discuss how Biofortuna can support your next project 💡 📍 Booth 3648 📲 Book a meeting today

Planning your ADLM itinerary? Here's 3 reasons to make sure Biofortuna are on your list. 📍 Booth 3648 📲 Book a meeting today

Newly published data from the VAPEUR RCT demonstrates that Rezūm™ Water Vapour Therapy can be adopted in routine practice for patients who would otherwise be directed to combination therapy. VAPEUR randomised clinical trial at 1-year reports that Rezūm Therapy can serve as an effective alternative to dual drug therapy, after alpha blockers fail, for the treatment of symptomatic BPH in sexually active men. CE0344

𝗛𝗮𝗻𝗱𝗵𝗲𝗹𝗱 𝘁𝗼𝗻𝗼𝗺𝗲𝘁𝗿𝘆 𝗲𝘃𝗼𝗹𝘃𝗲𝘀 𝘁𝗼 𝗻𝗲𝘅𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻. iCare IC1000™ introduces camera-based alignment assistance that guides operators to the correct measurement position. 𝗚𝘂𝗶𝗱𝗲𝗖𝗮𝗺 provides real-time positioning instructions, while 𝗔𝗨𝗧𝗢 𝗠𝗼𝗱𝗲 automatically starts the measurement when alignment is correct. These features reduce manual steps, minimize variability, and keep clinical routines efficient across varying levels of staff experience. 𝗤𝘂𝗶𝗰𝗸 𝗠𝗲𝗮𝘀𝘂𝗿𝗲 mode delivers results with fewer rebound measurements, giving clinicians the flexibility to adapt to every situation. Built on the legacy that extends over 20 years of reliable IOP measurement, iCare handheld tonometry is backed by over 300 clinical studies, demonstrating its proven reliability and reproducibility. 𝗟𝗲𝗮𝗿𝗻 𝗵𝗼𝘄 𝘁𝗵𝗲 𝗶𝗖𝗮𝗿𝗲 𝗜𝗖𝟭𝟬𝟬𝟬 𝗶𝘀 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗵𝗮𝗻𝗱𝗵𝗲𝗹𝗱 𝘁𝗼𝗻𝗼𝗺𝗲𝘁𝗿𝘆.

𝗶𝗖𝗮𝗿𝗲 𝗜𝗖𝟭𝟬𝟬𝟬 - 𝗛𝗮𝗻𝗱𝗵𝗲𝗹𝗱 𝘁𝗼𝗻𝗼𝗺𝗲𝘁𝗿𝘆 𝗲𝘃𝗼𝗹𝘃𝗲𝘀 𝘁𝗼 𝗻𝗲𝘅𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻. Building on decades of trusted iCare tonometry leadership, we have been committed to developing rebound technology for over 20 years. As the original developer, we continuously work to improve usability and reliability, providing healthcare professionals with the most advanced rebound tonometers on the market. Thanks to rebound technology, IOP results are obtained without the need for anesthesia, air puffs, or calibration. As a result of decades of trusted iCare expertise, the iCare IC1000 tonometer represents a clear step forward in intraocular pressure measurement. Combining clinical precision with intuitive, guided operation, it delivers reliable results fast and efficiently across a wide range of patients and clinical environments. 𝗟𝗲𝗮𝗿𝗻 𝗵𝗼𝘄 𝘁𝗵𝗲 𝗶𝗖𝗮𝗿𝗲 𝗜𝗖𝟭𝟬𝟬𝟬 𝗶𝘀 𝗿𝗲𝗱𝗲𝗳𝗶𝗻𝗶𝗻𝗴 𝗵𝗮𝗻𝗱𝗵𝗲𝗹𝗱 𝘁𝗼𝗻𝗼𝗺𝗲𝘁𝗿𝘆.

Too much of healthcare commercialization still runs on decks, emails, phone calls, and offline handshakes. Semantic Activation Platforms like Pathwai™ bring that work into a shared, online environment, connecting audience intelligence from planning through activation, measurement, and ongoing optimization.

A little appreciation goes a long way. Thank your pharmacist today.

🌟 Three Inspiring Days at the Biogen Benelux Cycle Meeting 2026 🌟 Recently colleagues from across Biogen Benelux came together in Leiden for our September Cycle Meeting. During three inspiring days, we connected, learned, and aligned around our shared ambition to create meaningful impact for patients and the healthcare community. A few highlights from our meeting: 🚀 Accelerating Patient Impact Through engaging discussions and collaborative workshops, we explored how we can continue to maximize the value of our innovations and strengthen our support for patients who may benefit from our therapies – turning innovation into meaningful impact for patients. 💙 Fenna’s Experience living with Friedreich's Ataxia (FA) One of the most memorable moments of the meeting was hearing the perspective of Fenna. "FA is a complex disease that affects every aspect of my life. Most people don't know what it is, so I often have to explain what I'm living with. Greater awareness wouldn't just help people understand the disease, it would help people like me feel seen and heard.“ – Fenna, 23 years old, ambassador for Spierziekte Nederland, living with Friedreich’s Ataxia 🧠 RISE in Motion: Unlocking our Agility We challenged ourselves to think differently, embrace new perspectives, and develop the agility needed to navigate an ever-evolving healthcare landscape. The conversations and reflections provided valuable insights that we can bring into our daily work and future collaborations. Because continued growth and development are not just about us - they strengthen the impact we can have for patients and the healthcare system. Beyond the sessions, the meeting provided an opportunity to strengthen connections, share experiences, and celebrate the collective commitment of our teams across Benelux. A big thank you to everyone who contributed to making these three days engaging, insightful, and energizing. Together, we continue to RISE: learning, collaborating, innovating, and strengthening our collective impact in service of people living with serious neurological and rare diseases. Biogen-295382 09/2026

Dialysis Clinic, Inc. invites you to join an organization dedicated to advancing kidney health through evidence-based practices and compassionate care. 🔗 Learn more about our mission-driven approach and find job openings near you: https://dciinc.jobs/

Simplify, Scale, and Take Control of Episode-Based Program Administration.

Volumes of data, complex cases, growing organizational pressure. For radiologists and healthcare IT, managing cognitive overload without compromising patient safety is a daily challenge. How can we turn this complexity into more efficient, connected clinical workflows? Artificial Intelligence is not about replacing physicians. It’s about augmenting their capabilities. Explore the opportunities, challenges and conditions shaping AI-assisted diagnostics. Read the full article on MORE Magazine: https://lnkd.in/eX6pjnxg #artificialintelligence #MORE #innovation #healthwithcare

Unlock functional insights with elive™ Test — an assay that uses your patient’s tumor to measure response to immunotherapy before you begin treatment. Learn more about the test and how to order: https://bit.ly/4z686er

Geographical barriers shouldn’t dictate access to quality care. For millions living in remote areas, managing chronic conditions often means fragmented treatments and delayed diagnoses. How can we bring continuous, high-quality care closer to where patients live? Telemedicine is moving beyond virtual visits. It’s about building patient-centered pathways that reduce hospital readmissions and emergency room visits through continuous monitoring. Technology makes this connection possible. The Elba Island experience shows what can happen when technology, healthcare professionals and well-designed clinical pathways work together to overcome distance. Read the full article on MORE Magazine: https://lnkd.in/dEY5RsNy #Telemedicine #MORE #Innovation #HealthWithCare

Make a real difference to breast imaging services across West Wales as a Consultant Radiologist with a specialist interest in Breast Radiology, joining a supportive and established team within Hywel Dda University Health Board. We are seeking a Consultant Radiologist with a specialist interest in Non-Vascular Interventional Radiology to join Hywel Dda University Health Board. This role offers the opportunity to combine a broad general radiology practice with a varied range of non-vascular interventional procedures, contributing to the delivery and continued development of radiology services across the region.

Residents are moving in with higher-acuity needs. See how Bluestone helps them safely age in place.

Residents deserve consistent care they can count on. See how Bluestone builds long-term relationships onsite.

Your current process with TrypLE works just fine. So why change it? Because a side-by-side comparison could show you what else is possible. We get it. Test CellTrypase in your own cells: Free sample + qualification guidance included and save 30 % for your orders in 2026!

Your enzyme works. But does your supply chain? If Accutase is part of your process today, CellTrypase could provide an additional option for your dissociation workflow. Test it in your own cells. Free sample and qualification guidance included.

What is changing the way early phase oncology trials are delivered? From specialized Phase I oncology centres to site networks and closer site-CRO collaboration, new approaches are reshaping early phase trial delivery. Dr Shiraj Sen, Director of Clinical Research at NEXT Oncology, IQVIA, shares his perspectives on what sponsors should consider when planning and executing early phase oncology trials. Explore the full 3-part video series.

You optimised the scaffold. Now the label has to fit it. A peptide that binds well is not automatically a peptide that images or treats well. The moment a radionuclide is attached, three new decisions take over: which isotope, which chelator, and which linker. Together they determine stability, biodistribution, clearance and where the activity ends up. Our miniguide sets out the design logic behind radiolabelled peptides: • Radionuclide selection for PET, SPECT and therapy, and why half-life has to match the biology rather than the modality • Chelator chemistry compared, from DOTA and NOTA to AAZTA and DFO, including the labelling conditions each one demands • Direct versus indirect labelling, and why prosthetic groups dominate 18F work on sensitive peptides • Peptide engineering for in vivo stability: D-amino acids, cyclization, N-alkylation, stapling • Kidney uptake as the dose-limiting problem in PRRT, and the strategies used to manage it • Where the field is heading: alpha emitters, novel theranostic pairs and click chemistry Written for teams moving a peptide from binder to radiopharmaceutical. Read the miniguide. ⬇️ #PeptideTherapeutics #Radiopharmaceuticals #DrugDiscovery #Theranostics #NuclearMedicine #MedicinalChemistry

Compare BrainsWay to first generation TMS and discover deeper, broader brain stimulation with proven clinical outcomes.

Blooming Day Maryland is Nov 13, join us in Annapolis or stream online! This is a one-day event uniting healthcare, social care, and government leaders to share strategies and insights, spark collaboration, and drive population health forward. Featuring a special message from Gov Wes Moore, and many more local leaders. See the full line up and register today!